Imaging Techniques for Mediastinal Mass Evaluation

Mediastinal masses encompass a broad spectrum of benign and malignant entities arising within the anterior, middle and posterior compartments of the thoracic cavity. Precise localisation and characterisation of these lesions underpin accurate diagnosis, optimal management and prognostication. Contrast-enhanced computed tomography (CT) remains the workhorse for initial detection, offering high spatial resolution to assess lesion size, density, calcification and relationships to adjacent structures. Multidetector CT with multiplanar reconstruction refines evaluation of vascular involvement and surgical planning. Magnetic resonance imaging (MRI) adds superior soft-tissue contrast, functional insight through diffusion-weighted sequences and targeted assessment of cystic versus solid components without ionising radiation. Positron emission tomography coupled with CT (PET-CT) contributes metabolic profiling and staging of malignancies. Recent advances in radiomics and machine learning applied to CT datasets have demonstrated enhanced discrimination between tumour subtypes and prediction of management pathways. Integration of imaging biomarkers with clinical and laboratory parameters is transforming mediastinal mass evaluation into a more personalised and less invasive discipline, with global implications for multidisciplinary care and resource utilisation.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

A recent study employed contrast-enhanced CT radiomics combined with clinical features to develop ensemble machine-learning models that distinguish patients requiring immediate surgery from those best served by pretreatment needle biopsy in prevascular mediastinal tumours. Two voting-based models achieved classification accuracies of 88.0 % and 90.4 %, outperforming standard clinical diagnosis and signalling the potential for radiomic decision support systems. A comprehensive review of mediastinal mass imaging highlighted the International Thymic Malignancy Interest Group (ITMIG) compartmentalisation scheme and underscored the complementary roles of multidetector CT and MRI in narrowing differential diagnoses. Key MRI applications included characterisation of tissue composition and evaluation of neurogenic, lymphatic and germinal tumours. In parallel, a multicentre analysis of chest MRI for anterior mediastinal cystic lesions proposed an MRI-based management algorithm: simple cysts demonstrated stable size and morphology over two years, while indeterminate lesions prompted targeted intervention. This approach promises to reduce unnecessary follow-ups and surgical procedures by harnessing reliable noninvasive imaging criteria.

Imaging Techniques for Mediastinal Mass Evaluation publication trend

The graph below shows the total number of articles in imaging techniques for mediastinal mass evaluation across all publications each year (not limited to Nature Index journals).

Technical terms

Contrast-enhanced computed tomography (CT): An imaging technique using intravenous iodinated contrast to improve lesion conspicuity and vascular delineation.

Multidetector CT (MDCT): A CT system with multiple detector rows that enables rapid acquisition of thin cross-sectional images and multiplanar reconstructions.

Radiomics: The extraction of quantitative features from medical images to characterise lesion heterogeneity and support predictive modelling.

Ensemble learning: A machine-learning strategy combining multiple algorithms to improve classification accuracy and robustness.

Diffusion-weighted MRI (DWI): A functional MRI sequence that measures the movement of water molecules within tissue, aiding differentiation of cystic and solid lesions.

Apparent diffusion coefficient (ADC): A quantitative index derived from DWI reflecting tissue cellularity and the integrity of cellular membranes.

References

1. Therapeutic Decision Making in Prevascular Mediastinal Tumors Using CT Radiomics and Clinical Features: Upfront Surgery or Pretreatment Needle Biopsy?. Cancers (2024).
2. Approach to Imaging of Mediastinal Masses. Diagnostics (2023).
3. Characteristics and outcomes of anterior mediastinal cystic lesions diagnosed on chest MRI: implications for management of cystic lesions. Insights into Imaging (2022).